Congress trade

Rep. Debbie Schultz (D-FL) bought $1K-$15K of Keryx Biopharmaceuticals, Inc. (KERX) stock

STOCK Act disclosure · Filed Feb 15, 2017

Debbie Schultz, U.S. Representative (D-FL), disclosed a purchase of Keryx Biopharmaceuticals, Inc. (KERX) stock worth $1K-$15K in a STOCK Act filing on Feb 15, 2017.

The trade happened on Feb 10, 2017, 5 days before it was made public.

Bought

KERX

Keryx Biopharmaceuticals, Inc.

Disclosed range

$1K-$15K

Traded: Feb 10, 2017
Disclosed: Feb 15, 2017
Filing delay: 5 days
Source: STOCK Act disclosure

See the filing

Other trades in this disclosure (1)

BuyCMTL$1K-$15KFeb 15, 2017

Share this trade

From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.